Aveanna Healthcare Holdings Inc（AVAH）财务数据AVAHAveanna Healthcare Holdings Inc

Aveanna Healthcare Holdings Inc (AVAH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Private Duty Service, accounting for 82.6% of total sales, equivalent to $553.93M. Other significant revenue streams include Our Home Health & Hospice and Medical Solutions. Understanding this composition is critical for investors evaluating how AVAH navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Aveanna Healthcare Holdings Inc maintains a gross margin of 32.17%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 12.58%, while the net margin is 6.01%. These profitability ratios, combined with a Return on Equity (ROE) of 198.57%, provide a clear picture of how effectively AVAH converts its operational activities into shareholder value.

In the context of the broader market, AVAH competes directly with industry leaders such as ACHC and MD. With a market capitalization of $2.71B, it holds a significant position in the sector. When comparing efficiency, AVAH's gross margin of 32.17% stands against ACHC's 100.00% and MD's 100.00%. Such benchmarking helps identify whether Aveanna Healthcare Holdings Inc is trading at a premium or discount relative to its financial performance.

Aveanna has shown strong revenue growth, with Q2 2026 revenues of $670.5 million, a 13.7% increase from the previous year. The net income for Q2 2026 was $40 million, significantly up from $27 million in Q2 2025, indicating improving profitability.